Standout Papers

Comparison of PAM50 Risk of Recurrence Score With Onco<i>type</i> DX and IHC4 for Predicting Risk ... 2013 2026 2017 2021 426
  1. Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy (2013)
    Mitch Dowsett, Ivana Šestak et al. Journal of Clinical Oncology

Immediate Impact

4 from Science/Nature 65 standout
Sub-graph 1 of 19

Citing Papers

A pan-cancer analysis of the microbiome in metastatic cancer
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
3 intermediate papers

Works of Sean Ferree being referenced

Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
2015
Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
2013 Standout
and 7 more

Author Peers

Author Last Decade Papers Cites
Sean Ferree 1596 1082 522 588 48 2.1k
Lila Zabaglo 1348 1204 389 409 37 1.9k
Elizabeth Mallon 1040 1005 324 704 32 2.0k
Ashutosh Nerurkar 1556 1169 695 741 41 2.2k
Arno Floore 1441 1270 338 1285 32 2.7k
Jonathan D. Marotti 1087 1298 494 611 83 2.4k
Stephen Braye 843 768 283 378 41 1.5k
Yi Zhang 1212 945 266 873 24 2.0k
Eva Carrasco 1093 1424 466 348 76 1.9k
Catherine A. Schnabel 1203 1019 584 1142 103 2.7k
Véronique Becette 963 1019 402 874 53 2.2k

All Works

Loading papers...

Rankless by CCL
2026